Skip to main content
Geratherm Medical AG logo

Geratherm Medical AG — Investor Relations & Filings

Ticker · GME ISIN · DE0005495626 LEI · 391200RRY20H0XD6QC53 F Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 483 across all filing types
Latest filing 2024-09-18 M&A Activity
Country DE Germany
Listing F GME

About Geratherm Medical AG

https://geratherm.com/

Geratherm Medical AG is a medical technology company that develops and produces a range of medical devices and solutions for both professional and home use. For the professional market, the company provides systems for pulmonary function diagnostics, including spirometry, pulmonary function tests (PFT), and cardiopulmonary stress tests (CPET). It also offers specialized equipment such as the nomag®IC advanced, an MR diagnostics incubator system for newborns. For the consumer and home care market, Geratherm offers a portfolio of healthcare diagnostic products designed to monitor vital data. This includes clinical thermometers, blood pressure monitors, and products for women's health, such as pregnancy tests and tools for natural family planning.

Recent filings

Filing Released Lang Actions
Geratherm Medical AG: Verkauf des Tochterunternehmens apoplex medical technologies GmbH an Deutsch-Amerikanisches Konsortium fur rd. 16,5 Mio. EURO
M&A Activity Classification · 99% confidence The document is an 'Ad-hoc' announcement dated September 18, 2024, published under Article 17 of the EU Market Abuse Regulation (MAR), indicating it is a mandatory disclosure of inside information. The core content details the sale of a subsidiary (apoplex medical technologies GmbH) for approximately 16.5 million EUR. This type of announcement, concerning a significant corporate transaction (divestiture/sale), does not fit neatly into standard periodic reports (10-K, IR) or specific financial events (ER, DIV). It relates to a major change in corporate structure/financing activity. While it is a significant corporate event, it is not explicitly a 'Capital/Financing Update' (CAP) which usually covers fundraising or debt issuance, nor is it M&A activity (TAR) which typically covers proposals or bids. Given the nature of mandatory, immediate disclosure of a major transaction that impacts the company's structure and value, and since it is a general regulatory disclosure that doesn't fit the other specific categories, the most appropriate fallback is 'Regulatory Filings' (RNS), as it is an immediate, non-periodic regulatory disclosure via EQS News.
2024-09-18 German
Halbjahresabschluss 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresbericht 2024' (Half-Year Report 2024) for Geratherm Medical AG. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement for the period ending June 30, 2024. It provides a detailed management discussion and analysis of the business performance, regional sales, and outlook. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. H2 2024
2024-08-15 German
Report Publication Announcement 2024
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports..." and explicitly states that a financial report (specifically, the 'Financial report of the group (half-year/Q2)') will be disclosed on a future date (August 15, 2024). The current document's purpose is solely to announce the upcoming release of this report, not to contain the report itself. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published qualifies as a Report Publication Announcement (RPA). The document is very short (1793 characters) and serves this exact purpose.
2024-08-12 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2024 bis zum 30.06.2024
Report Publication Announcement Classification · 98% confidence The document is very short (811 characters) and explicitly functions as a notice ('Hinweis auf Halbjahresfinanzbericht'). It states that the 'Halbjahresfinanzbericht' (Half-Year Financial Report) for the period 01.01.2024 to 30.06.2024 is available on the internet starting 15.08.2024. This structure—a brief announcement pointing to the full report—fits the definition of a Report Publication Announcement (RPA). It is not the comprehensive Interim Report (IR) itself, but the notice of its publication.
2024-08-12 German
Jahresabschluss 2023
Annual Report Classification · 100% confidence The document is titled 'Geschäftsbericht 2023' (Annual Report 2023) for Geratherm Medical AG. It contains comprehensive sections including the Report of the Supervisory Board, Report of the Management Board, Group Management Report (Konzernlagebericht), and detailed financial statements (Konzernabschluss) such as the balance sheet, income statement, and cash flow statement. It is clearly the full annual report for the fiscal year 2023, not an announcement or a summary. FY 2023
2024-06-20 German
Report Publication Announcement 2024
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that the company is announcing *when* and *where* the financial reports (specifically the Annual financial report of the group) will be disclosed on a future date (June 20, 2024). This fits the definition of announcing the publication of a report rather than being the report itself. Given the short length (1781 chars) and the content focusing on the announcement of publication, the most appropriate classification is Report Publication Announcement (RPA).
2024-06-18 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.